Peter Slipper wrote, "Resapp Health will need a cornerstone or angel investor if the appalling Scheme BOD has forced upon its shareholders gets voted down. Resapp's respiratory technology IS CUTTING EDGE CLINICALLY PROVEN. BOD??"
"The approach of the RAP Board in encouraging shareholders effectively to donate their shares to Pfizer is disgusting beyond belief and worthy of sacking! While I’m not suggesting Pfizer has paid for this recommendation why has Board done this? VOTE NO! VOTE NO! VOTE NO! VOTE NO!" I think he nailed it right there.
RAP Price at posting:
12.5¢ Sentiment: None Disclosure: Held